| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/02/2001 | CA2396596A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | CA2396372A1 Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2395730A1 Selective estrogen receptor modulators in combination with estrogens |
| 08/02/2001 | CA2395446A1 Compositions, kits, and methods for cardiovascular health |
| 08/02/2001 | CA2395298A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/02/2001 | CA2394525A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | CA2394332A1 Chimeric neuropeptide y receptors |
| 08/01/2001 | EP1120723A2 Identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists and associated pharmacophore models and screening methods |
| 08/01/2001 | EP1120114A2 Compositions and methods for treating conditions responsive to estrogen |
| 08/01/2001 | EP1120113A2 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormone |
| 08/01/2001 | EP1119772A1 A novel ret-independent signaling pathway for gdnf |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119557A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 08/01/2001 | EP1119555A1 Biphenylene lactams as prostaglandin receptor ligands |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | EP1119529A2 Chemical constructs |
| 08/01/2001 | EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 08/01/2001 | EP1119372A1 Composition and method for treating allergic diseases |
| 08/01/2001 | EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 08/01/2001 | EP1119370A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 08/01/2001 | EP1119361A2 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 08/01/2001 | EP1119360A1 Methods and compositions for increasing intestinal absorption of fats |
| 08/01/2001 | EP1119354A1 Peripherally acting anti-pruritic opiates |
| 08/01/2001 | EP1119353A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 08/01/2001 | EP1119350A2 Rar antagonists as male anti-fertility agents |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119334A1 Two chamber cartridge for atomizers |
| 08/01/2001 | EP1119251A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
| 08/01/2001 | EP0820308B1 Conjugate for treating inflammatory diseases |
| 08/01/2001 | EP0806963B1 Carcinoma treatment |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | EP0569583B1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306540A Prodrugs of dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306515A Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306430A Combinations comprising VX478, zidovuding and/or 1592U89 for use in treatment of HIV |
| 08/01/2001 | CN1306426A Use of compounds for anti-pruritic activity |
| 08/01/2001 | CN1306423A Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 08/01/2001 | CN1306413A Foaming compsn. for hair care |
| 08/01/2001 | CN1305791A Stretchable hood utensil contg. stretchable adhesive matrix at least in moisture state |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268394 Contacting a cell with an amount of a sesquiterpene lactone |
| 07/31/2001 | US6268393 Calanolides and analogues thereof |
| 07/31/2001 | US6268392 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| 07/31/2001 | US6268382 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 07/31/2001 | US6268378 Integrin receptor antagonists |
| 07/31/2001 | US6268377 Method for treating androgen-related conditions |
| 07/31/2001 | US6268374 Uracil reductase inactivators |
| 07/31/2001 | US6268354 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative |
| 07/31/2001 | US6268352 Promoters of neural regeneration |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268163 Identification of drug candidates modulating factor VII-mediated intracellular signaling |
| 07/31/2001 | US6268011 Mixture of soybean protein and soybean fiber |
| 07/31/2001 | US6267972 Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists |
| 07/31/2001 | US6267957 Attaching agents to tissue with transglutaminase and a transglutaminase substrate |
| 07/31/2001 | US6267955 Mononuclear phagocytes and their use to promote axonal regeneration |
| 07/31/2001 | CA2332687A1 Use of prostaglandin (pge2) receptor 4 (ep4) selective agonists for the treatment of acute and chronic renal failure |
| 07/31/2001 | CA2068763C Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 07/26/2001 | WO2001053835A2 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053469A2 Phosphatases |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053444A1 Antimicrobial compositions |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053351A2 Apoptin bindendes protein |
| 07/26/2001 | WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053339A2 Egg specific surface proteins |
| 07/26/2001 | WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001053321A2 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers |
| 07/26/2001 | WO2001053311A1 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053289A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053254A1 Calcilytic compounds |
| 07/26/2001 | WO2001052904A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052876A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052870A1 Treatment of congestive heart failure by pretreated autologous blood |
| 07/26/2001 | WO2001052868A1 Combinations for treating neoplasms |
| 07/26/2001 | WO2001052866A1 Dextrin containing compositions for prevention of adhesions |
| 07/26/2001 | WO2001052860A2 Method and composition for modulating an immune response |
| 07/26/2001 | WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate |
| 07/26/2001 | WO2001052858A1 Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| 07/26/2001 | WO2001052854A1 Nk1-receptor antagonists for treatment of restless legs syndrome |